A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

Trial Profile

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2013

At a glance

  • Drugs Efavirenz; Fosamprenavir; Lamivudine/abacavir; Ritonavir
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SUPPoRT
  • Most Recent Events

    • 15 Oct 2011 Results presented at the 13th European AIDS Conference.
    • 14 Oct 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
    • 14 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top